Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 36 studies | 38% ± 14% | |
endothelial cell | 30 studies | 32% ± 16% | |
pericyte | 27 studies | 29% ± 12% | |
smooth muscle cell | 22 studies | 28% ± 10% | |
endothelial cell of lymphatic vessel | 14 studies | 33% ± 15% | |
adipocyte | 10 studies | 57% ± 9% | |
connective tissue cell | 9 studies | 27% ± 7% | |
myofibroblast cell | 9 studies | 28% ± 10% | |
vein endothelial cell | 8 studies | 29% ± 13% | |
epithelial cell | 8 studies | 33% ± 16% | |
type I pneumocyte | 7 studies | 34% ± 14% | |
endothelial cell of vascular tree | 7 studies | 22% ± 9% | |
type II pneumocyte | 6 studies | 25% ± 7% | |
astrocyte | 6 studies | 34% ± 7% | |
capillary endothelial cell | 5 studies | 26% ± 9% | |
endothelial cell of artery | 4 studies | 27% ± 13% | |
mesothelial cell | 4 studies | 28% ± 15% | |
cardiac muscle cell | 4 studies | 20% ± 6% | |
GABAergic neuron | 4 studies | 39% ± 14% | |
glutamatergic neuron | 4 studies | 48% ± 17% | |
abnormal cell | 3 studies | 34% ± 16% | |
placental villous trophoblast | 3 studies | 25% ± 5% | |
basal cell | 3 studies | 37% ± 25% | |
neuron | 3 studies | 19% ± 3% | |
muscle cell | 3 studies | 47% ± 20% | |
oligodendrocyte precursor cell | 3 studies | 22% ± 4% | |
adventitial cell | 3 studies | 33% ± 4% | |
Schwann cell | 3 studies | 31% ± 8% | |
granule cell | 3 studies | 19% ± 3% | |
interneuron | 3 studies | 37% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 99% | 14104.58 | 179 / 180 | 99% | 114.36 | 426 / 430 |
lung | 100% | 24303.48 | 578 / 578 | 98% | 112.99 | 1137 / 1155 |
breast | 100% | 32901.83 | 459 / 459 | 96% | 103.77 | 1076 / 1118 |
thymus | 100% | 15898.36 | 650 / 653 | 97% | 124.44 | 584 / 605 |
skin | 96% | 38511.23 | 1738 / 1809 | 99% | 200.46 | 466 / 472 |
bladder | 100% | 26547.76 | 21 / 21 | 94% | 73.00 | 476 / 504 |
intestine | 99% | 24825.74 | 955 / 966 | 95% | 70.69 | 501 / 527 |
esophagus | 95% | 24910.51 | 1370 / 1445 | 98% | 126.22 | 180 / 183 |
uterus | 99% | 22913.39 | 169 / 170 | 91% | 96.31 | 417 / 459 |
prostate | 87% | 10032.53 | 213 / 245 | 97% | 73.97 | 486 / 502 |
stomach | 81% | 17461.11 | 289 / 359 | 97% | 92.07 | 278 / 286 |
kidney | 54% | 4990.19 | 48 / 89 | 97% | 130.60 | 874 / 901 |
adrenal gland | 77% | 5621.76 | 199 / 258 | 73% | 38.43 | 169 / 230 |
pancreas | 38% | 2586.07 | 125 / 328 | 97% | 101.28 | 173 / 178 |
adipose | 100% | 45649.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 31932.53 | 1335 / 1335 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 61.48 | 1 / 1 |
heart | 98% | 15588.60 | 842 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 80.98 | 44 / 45 |
muscle | 98% | 11639.81 | 784 / 803 | 0% | 0 | 0 / 0 |
liver | 4% | 288.41 | 10 / 226 | 80% | 65.19 | 324 / 406 |
eye | 0% | 0 | 0 / 0 | 81% | 40.97 | 65 / 80 |
lymph node | 0% | 0 | 0 / 0 | 62% | 26.11 | 18 / 29 |
brain | 1% | 88.91 | 38 / 2642 | 51% | 34.54 | 361 / 705 |
peripheral blood | 12% | 866.36 | 113 / 929 | 0% | 0 | 0 / 0 |
spleen | 8% | 501.20 | 19 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051149 | Biological process | positive regulation of muscle cell differentiation |
GO_0022617 | Biological process | extracellular matrix disassembly |
GO_2001046 | Biological process | positive regulation of integrin-mediated signaling pathway |
GO_0007155 | Biological process | cell adhesion |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0050679 | Biological process | positive regulation of epithelial cell proliferation |
GO_0007492 | Biological process | endoderm development |
GO_0034446 | Biological process | substrate adhesion-dependent cell spreading |
GO_0035633 | Biological process | maintenance of blood-brain barrier |
GO_0031581 | Biological process | hemidesmosome assembly |
GO_0110011 | Biological process | regulation of basement membrane organization |
GO_0016477 | Biological process | cell migration |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0070062 | Cellular component | extracellular exosome |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005606 | Cellular component | laminin-1 complex |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0043259 | Cellular component | laminin-10 complex |
GO_0043260 | Cellular component | laminin-11 complex |
GO_0098637 | Cellular component | protein complex involved in cell-matrix adhesion |
GO_0005604 | Cellular component | basement membrane |
GO_0030023 | Molecular function | extracellular matrix constituent conferring elasticity |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
Gene name | LAMC1 |
Protein name | Laminin subunit gamma 1 LAMC1 protein Laminin subunit gamma-1 (Laminin B2 chain) (Laminin-1 subunit gamma) (Laminin-10 subunit gamma) (Laminin-11 subunit gamma) (Laminin-2 subunit gamma) (Laminin-3 subunit gamma) (Laminin-4 subunit gamma) (Laminin-6 subunit gamma) (Laminin-7 subunit gamma) (Laminin-8 subunit gamma) (Laminin-9 subunit gamma) (S-laminin subunit gamma) (S-LAM gamma) |
Synonyms | LAMB2 |
Description | FUNCTION: Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. |
Accessions | ENST00000258341.5 P11047 R4GNC7 Q6NVY8 ENST00000484114.2 |